Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Quackenbush, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture
Other Positions
Title
Institution
Department

Overview
John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard T.H. Chan School of Public Health, Professor in the Channing Division of Network Medicine, and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics, but in 1992 he received a fellowship to work on the Human Genome Project. This led him through the Salk Institute, Stanford, The Institute for Genomic Research (TIGR), and to Harvard in 2005. John uses massive data to probe how many small effects combine to influence human health and disease. He has more than 300 scientific papers and over 73,000 citations. Among his honors is recognition in 2013 as a White House Open Science Champion of Change.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HG011393 (DEMEO, DAWN L) Sep 1, 2021 - Jun 30, 2025
    NIH
    Networks Tools to Understand Sex- and Gender-Specific Drivers of Disease
    Role: Co-Principal Investigator
  2. U24CA231846 (QUACKENBUSH, JOHN) Sep 1, 2019 - Aug 31, 2024
    NIH
    WebMeV: A Robust Platform for Intuitive Genomic Data Analysis
    Role: Principal Investigator
  3. R35CA220523 (QUACKENBUSH, JOHN) Sep 1, 2018 - Aug 31, 2025
    NIH
    Unraveling the Complexities of Risk and Mechanism in Cancer
    Role: Principal Investigator
  4. T32LM012411 (QUACKENBUSH, JOHN) Apr 1, 2016 - Mar 31, 2021
    NIH
    Statistical and Quantitative Training in Big Data Health Science
    Role: Principal Investigator
  5. U24CA194354 (AERTS, HUGO) Apr 1, 2015 - Mar 31, 2021
    NIH
    Quantitative Radiomics System Decoding the Tumor Phenotype
    Role: Co-Principal Investigator